New molecular imaging techniques that will enable to detect ER presence and distribution in vivo, in both primary and metastatic cancer lesions, could improve accuracy and reproducibility of prognostic assessment and therapy management of breast cancer patients. The gene discussed is ESR1; the disease is metastatic malignant neoplasm.